NewAmsterdam Pharma Co N.V.
NAMSW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.
Other share classesNAMS
Q4 2022 vs. Q3 2022
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 22 | +22 |
| Shares | 0 | 1.93M | +1.93M |
| Value | $0 | $1.91M | +$1.91M |
New holders (22)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | – | $564.0K | 0.02% |
| Frazier Life Sciences Management, L.P. | 500,333 | $434.3K | 0.03% |
| Ra Capital Management, L.P. | 333,333 | $289.4K | 0.01% |
| Ensign Peak Advisors, Inc | 150,000 | $120.0K | 0.00% |
| Exos TFP Holdings LLC | 137,317 | $119.2K | 0.03% |
| Bain Capital Life Sciences Investors, LLC | 100,000 | $86.0K | 0.01% |
| Deerfield Management Company, L.P. (Series C) | 92,787 | $80.6K | 0.00% |
| Castle Creek Arbitrage, LLC | 51,520 | $43.0K | 0.00% |
| PEAK6 Investments LLC | 40,033 | $34.8K | 0.00% |
| Westchester Capital Management, LLC | 31,189 | $25.0K | 0.00% |
| Walleye Capital LLC | 28,388 | $24.6K | 0.00% |
| HRT Financial LP | 30,321 | $24.0K | 0.00% |
| Caxton Corp | 21,333 | $17.8K | 0.05% |
| Walleye Trading LLC | 16,356 | $14.2K | 0.00% |
| Laurion Capital Management LP | 16,666 | $13.3K | 0.00% |
| Vestcor Inc | 9,632 | $8.00K | 0.00% |
| DuPont Capital Management Corp | 8,333 | $6.67K | 0.00% |
| Mint Tower Capital Management B.V. | 6,533 | $6.00K | 0.00% |
| Wolverine Asset Management LLC | 1,462 | $1.27K | 0.00% |
| UBS Group AG | 1,076 | $936 | 0.00% |
| Alyeska Investment Group, L.P. | 285,105 | – | – |
| EcoR1 Capital, LLC | 66,665 | – | – |
Sold out (0)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2022 and filed for Q4 2022 without it.
None.